Dr. Laura Esserman on Breast Cancer Risk Assessments and The WISDOM Study (KPIX March 2024)

Cancer Data: Improve Screening and Breast Cancer Awareness with Dr. Laura EssermanПодробнее

The Future of Breast Cancer Screening and Detection - The WISDOM StudyПодробнее

WISDOM: Assuring Tomorrow is Better than Today | Laura Esserman | TEDxBerkeleyПодробнее

Breast Cancer Screening and Wisdom TrialПодробнее

Reinventing Clinical Trials with Laura EssermanПодробнее

Latest Advances in Systemic Treatment for Breast Cancer: Evidence and ImplicationsПодробнее

ABCF| DCIS Advocate ChatПодробнее

Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer ManagementПодробнее

Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug ConjugatesПодробнее

Dr. Esserman on Screening Patients With Higher-Risk DCISПодробнее

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast CancerПодробнее

Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding t...Подробнее

Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast CancerПодробнее

2010 SABCS Interview with Laura Esserman, M.D., M.B.A.Подробнее

Optimizing Adjuvant Treatment of Early Breast Cancer: Where Are We Today?Подробнее